Is Cannabis Stock Cannapharmarx Inc (CPMD) in the Bottom of the Drug Manufacturers

Is Cannabis Stock Cannapharmarx Inc (CPMD) in the Bottom of the Drug Manufacturers - Specialty & Generic Industry Thursday?

Thursday, February 17, 2022 01:25 PM | InvestorsObserver Analysts

Mentioned in this article

Is Cannabis Stock Cannapharmarx Inc (CPMD) in the Bottom of the Drug Manufacturers - Specialty & Generic Industry Thursday?

Cannabis stock Cannapharmarx Inc is higher by 11.2% Thursday. Cannapharmarx Inc (CPMD) is near the bottom in its industry group according to InvestorsObserver. CPMD gets an overall rating of 7. That means it scores higher than 7 percent of stocks. Cannapharmarx Inc gets a 8 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 142 out of 148 industries.

CPMD has an Overall Score of 7. Find out what this means to you and get the rest of the rankings on CPMD!

See Full CPMD Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cannapharmarx Inc Stock Today?

Cannapharmarx Inc (CPMD) stock is flat 11.2% while the S&P 500 has fallen -1.31% as of 11:44 AM on Thursday, Feb 17. CPMD is flat $0.00 from the previous closing price of $0.02 on volume of 355,846 shares. Over the past year the S&P 500 is up 12.34% while CPMD has fallen -93.75%. CPMD lost -$0.35 per share the over the last 12 months. Click Here to get the full Stock Report for Cannapharmarx Inc stock.